Rescue fusion hybridization

Rescue fusion hybridization is a process used to manufacture some therapeutic cancer vaccines in which individual tumor cells obtained through biopsy are fused with an antibody-secreting cell to form a heterohybridoma. This cell then secretes the unique idiotype, or immunoglobulin antigen characteristic of the individual tumor, which is purified for use as the vaccine.[1]

It is used to produce the BiovaxID vaccine for follicular lymphoma.

References
  1. "What Comes After Dendreon's Provenge?". 18 Oct 2010.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.